Knee surgery for torn cartilage may not be worthwhile
(Reuters Health) – Many middle-aged and older adults with torn cartilage and pain in their knee are not likely to benefit from so-called arthroscopic surgery, a review of past studies…
Exclusive: OxyContin maker Purdue Pharma exploring bankruptcy – sources
(Reuters) – OxyContin maker Purdue Pharma LP is exploring filing for bankruptcy to address potentially significant liabilities from roughly 2,000 lawsuits alleging the drugmaker contributed to the deadly opioid crisis…
Insys founder ran bribe scheme to push opioid: U.S. prosecutor
BOSTON (Reuters) – Insys Therapeutics Inc’s one-time billionaire founder directed a vast scheme to bribe doctors to prescribe an addictive fentanyl spray as opioid addiction was spiraling into a public…
U.S. regulators snip red tape for medical devices to curb opioid crisis
(Reuters) – Laura Perryman expected her medical company, Stimwave Technologies Inc, would have to wait several years for its painkilling device to win U.S. approval as a treatment for chronic…
Women’s sexual health after menopause may be best treated by gynecologists
(Reuters Health) – Postmenopausal women who experience problems like vaginal dryness, painful intercourse or urinary incontinence may want to see a gynecologist instead of a primary care provider for help,…
Yes, cuddles can help ease babies’ pain from needle sticks
(Reuters Health) – Babies have long been offered a bit of sugar water or breastmilk to comfort them during needle sticks, and a new study suggests these methods of pain…
Shingrix vaccine makes shingles less severe, disruptive to quality of life
(Reuters Health) – The vaccine Shingrix prevents shingles, and if people do contract the virus, it reduces the severity of illness, two company-funded study suggests. Shingles, also known as herpes…
Opioid reclassification linked to increase in illegal online sales
(Reuters Health) – Online black-market sales of opioid painkillers more than doubled in the United States during the two years after these drugs were “rescheduled,” putting tighter restrictions on legal…
U.S. medical device firm electroCore IPO price set at $15 per share
(Reuters) – U.S. medical device maker electroCore Llc’s initial public offering is expected to price at $15 per share, Chief Executive Officer Frank Amato told Reuters on Thursday. ElectroCore, which…
Opioids overprescribed to patients taking certain sedatives
(Reuters Health) – Narcotic painkillers can be particularly dangerous for patients who also take tranquilizing drugs known as benzodiazepines, but a study suggests doctors are still over-prescribing this combination of…